Vol. 6, No. 12
Drug-related health problems cause needless suffering and waste billions of dollars. Consultant pharmacists say they can help.
The intensity of gatekeeping has changed. Responding to market pressures, most plans are easing referral requirements or doing away with them altogether. Will higher costs and poorer medicine result?
The Joint Commission's president says it may be just as well that managed care can't agree on one HMO accrediting agency just yet.
The American Diabetes Association has proposed stronger screening guidelines. With the disease at an all-time high, will plans go along?
HMO copayment amounts aren't just picked out of thin air. Because utilization and physician revenue are at stake, setting them is tricky.
Editor's Memo 5
News and Commentary 9
Compensation Monitor 16
Washington Initiatives 17
State Initiatives 19
Employer Update 20A
Legal Forum 59
Managed Care Outlook 62